相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apolipoproteins in vascular biology and atherosclerotic disease
Anurag Mehta et al.
NATURE REVIEWS CARDIOLOGY (2022)
Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study
Han Cen et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2022)
Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: A systematic review and meta-analysis
Samuel J. Tu et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2021)
Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review
Johanna Raymond et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Jennifer Behbodikhah et al.
METABOLITES (2021)
Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
Xinxing Gao et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users
Jaakko Lahteenmaki et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Association of apolipoprotein B XbaI (rs693) polymorphism and gallstone disease risk based on a comprehensive analysis
Haifeng Zhu et al.
GENES AND ENVIRONMENT (2021)
LRP1 and APOA1 Polymorphisms: Impact on Warfarin International Normalized Ratio-Related Phenotypes
Dan Li et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Validation of Bleeding Risk Prediction Scores for Patients With Major Bleeding on Direct Oral Anticoagulants
Stephanie Tchen et al.
ANNALS OF PHARMACOTHERAPY (2020)
The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation A PRISMA-compliant article
Xuyang Liu et al.
MEDICINE (2020)
Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review
Allen Li et al.
THROMBOSIS RESEARCH (2020)
Risk factors for intracerebral haemorrhage - Results from a prospective population-based study
Edith H. Svensson et al.
EUROPEAN STROKE JOURNAL (2020)
Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies
Jessika Lobraico-Fernandez et al.
DRUGS IN R&D (2019)
APOB gene polymorphisms may affect the risk of minor or minimal bleeding complications in patients on warfarin maintaining therapeutic INR
Jeong Yee et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2019)
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
Tze-Fan Chao et al.
EUROPEAN HEART JOURNAL (2019)
Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention
Ruka Yoshida et al.
JOURNAL OF CARDIOLOGY (2019)
Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world
Madan Raj Aryal et al.
BLOOD ADVANCES (2019)
Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?
Noel Chan et al.
AMERICAN HEART JOURNAL (2018)
Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures: a systematic review and meta analysis
C. Bensi et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2018)
A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants
Z. Wolfe et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Association between apolipoprotein B genetic polymorphism and the risk of calcific aortic stenosis in Chinese subjects, in Xinjiang, China
Yong-Tao Wang et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk
Yitian Zhou et al.
JOURNAL OF LIPID RESEARCH (2018)
Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines
Anne-Laure Sennesael et al.
SCIENTIFIC REPORTS (2018)
Effect of ABCB1 Genotypes on the Pharmacokinetics and Clinical Outcomes of New Oral Anticoagulants: A Systematic Review and Meta-analysis
Qiufen Xie et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis
Caiqin Niu et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation
Satoshi Ueshima et al.
PHARMACOGENETICS AND GENOMICS (2017)
Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures
David Deutsch et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
B. Daan Westenbrink et al.
AMERICAN HEART JOURNAL (2017)
HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease
Lucas D. Ward et al.
NUCLEIC ACIDS RESEARCH (2016)
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability
Claudia Dimatteo et al.
THROMBOSIS RESEARCH (2016)
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect
Kuntheavy Ing Lorenzini et al.
FRONTIERS IN PHARMACOLOGY (2016)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
VKORC1 and CYP2C9 genotype distribution in Asian countries
Tejasvita Gaikwad et al.
THROMBOSIS RESEARCH (2014)
Polymorphisms Xbal (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2
Jovana Nikolajevic Starcevic et al.
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2014)
Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban
Inna Y. Gong et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Associations of Polymorphisms of rs693 and rs1042031 in Apolipoprotein B Gene With Risk of Breast Cancer in Chinese
Xiaoyi Liu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
Novel Oral Anticoagulants: A Review of New Agents
Matthew A. Wanat
POSTGRADUATE MEDICINE (2013)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
Stavros Apostolakis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans
Jackson K. Mukonzo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Substrate-dependent effects of human ABCB1 coding polymorphisms
Jason M. Gow et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism.: Findings from the RIETE Registry
Nuria Ruiz-Gimenez et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage?: Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls
C Sudlow et al.
STROKE (2006)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
分享论文
